The CyberKnife Robotic Radiosurgery System is a noninvasive alternative to surgery for the treatment of tumors anywhere in the body—with fewer side effects. Cyberknife treatment delivers very high doses of radiation to tumors with extreme accuracy. There is no anesthesia, no pain and minimal recovery time. It’s like having an X-ray; you don’t feel anything. In fact, in most cases, patients can return to normal activity the next day.
Unlike traditional radiosurgery systems that can only treat tumors in the skull, Cyberknife can treat tumors anywhere, including the lung, pancreas, liver, spine and prostate. The system’s advanced maneuverability offers complete access and coverage for any tumor size or shape, even in difficult-to-reach areas. This means maximal radiation doses can be delivered for the greatest benefit with minimal damage to surrounding healthy tissues and organs.
For men receiving prostate cancer radiation therapy, the Cyberknife team is introducing the use of SpaceOAR (Organs at Risk) hydrogels to protect the rectum from injury and thereby improve outcomes.
We are the only center in Delaware to introduce this advanced protection for prostate cancer therapy.
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road,
Newark, DE 19713